InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Nemec Sarah. Director active across 1 company, notably Bolt Biotherapeutics, Inc.. Aggregated, 3 reports have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €2k. History available since 16 December 2024. The latest transaction was filed on 5 December 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条